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I
INTRODUCTION
On December 11, 1991, the Journal of the American Medical Association
(“JAMA”) published three studies that examined the effect of the Camel ciga-
rette “Old Joe” advertising campaign on adolescents and children.1  I was lead
author on the study that showed that “Old Joe” was nearly universally recog-
nized by six-year-old children, a level of awareness that matched the logo for
the Disney channel.  Because cigarette smoking is the leading preventable
cause of death and disease in this country, I recognized that this research might
play a prominent role in the subsequent debate about tobacco advertising.  As
a scientist, I naively assumed that this discourse would be conducted in aca-
demic journals based upon rigorous research and leading to an improved un-
derstanding of whether and how advertising influences adolescent experimen-
tation with cigarettes.  To date, most of the subsequent debate has occurred in
court.
From the beginning, the tobacco industry attempted to discredit this re-
search and harass the researchers.  My experience in confronting the tobacco
industry has taught me how easily the courts can become the unwitting accom-
plices of an industry whose goal is profit, not the identification of scientific
truth.  In his paper in this issue of Law and Contemporary Problems, Michael
Traynor states that with “common sense and goodwill in every quarter” there
should be few problems due to compelled discovery of scholarly research.2  Un-
fortunately, in some cases, neither common sense nor goodwill prevail.  In such
cases, the court can become an instrument of abuse.
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dren, 266 JAMA 3149 (1991); Paul M. Fischer et al., Brand Logo Recognition by Children Aged 3 to 6
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bacco Advertising Target Young People to Start Smoking?, 266 JAMA 3154 (1991).
2. Michael Traynor,  Countering the Excessive Subpoena for Scholarly Research, 59 LAW &
CONTEMP. PROBS. 119, 148 (Summer 1996).
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II
MY INTRODUCTION TO EXCESSIVE SUBPOENAS
A.  A Chronology of Events
The “Old Joe” studies were published in a JAMA theme issue dealing with
tobacco research.3  The American Medical Association also held a press con-
ference in New York to present the findings,4 which received wide coverage in
the press.5
On March 9, 1992, The American Medical Association, the Surgeon Gen-
eral, the American Cancer Society, the American Heart Association, and the
American Lung Association called for a ban on “Old Joe” advertising attrac-
tive to children.6  The following day, James Johnson, C.E.O. of the R.J. Rey-
nolds Tobacco Company (“RJR”), defended “Old Joe” in an interview pub-
lished on the editorial page of U.S.A. Today.7  In this interview, he attacked the
“Old Joe” studies and its researchers.8  Mr. Johnson argued that the “studies
are flawed in very serious ways.  The scientists who wrote these studies are not
unbiased.”9  He made two specific claims about our research that were not true.
He stated that the sample size was twenty three people10 when in reality it was
229 people.  He also claimed that we called the parents of the three- to six-year-
old children in our study the night before the data collection and asked them
only about cigarette use.11  This statement was a total fabrication.  Such a call to
the parents would have obviously biased the results.
On March 27, I was served a subpoena duces tecum by RJR.12  A suit had
been filed in California by Janet Mangini against RJR, based on RJR’s failure
to place health warnings on promotional products such as Camel caps and t-
shirts.13  I received the subpoena even though my research had not been named
in the Mangini complaint, I was not a witness to either side in the case, and my
1991 JAMA research had no bearing on the issue of health warnings.
The subpoena ordered me to produce the following: the names and tele-
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4. See Stuart Elliott, Top Health Official Demands Abolition of “Joe Camel” Ads, N.Y. TIMES,
Mar. 10, 1992, at A1.
5. See, e.g., Jane E. Brody, Smoking Among Children Is Linked to Cartoon Camel in Advertise-
ments, N.Y. TIMES, Dec. 11, 1991, at D22.
6. Elliott, supra note 4.





12. Defendant’s Notice of Out of State Deposition on Oral Examination and Request for Produc-
tion of Documents and Things,  Mangini v. R.J. Reynolds Tobacco Co., No. 939359 (Super. Ct., San
Francisco Cty., Cal., Mar. 30, 1992).
13. See Mangini v. R.J. Reynolds Tobacco Co., 21 Cal.Rptr.2d 232 (Cal. Ct. App.), rev. granted &
opinion superseded, 859 P.2d 672 (Cal. 1993), cert. denied, 875 P.2d 73 (Cal. 1994) (en banc), cert de-
nied, 115 S. Ct. 577 (1994).
FISCHER.FMT 08/13/97  2:45 PM
Page 159:  Summer 1996] SCIENCE AND SUBPOENAS 161
phone numbers of all of the children who participated in the study; all drafts of
the study design; all notes, memos, and videotapes pertaining to the study; the
names, addresses, telephone numbers, background information, and occupa-
tions of all interviewers; hard copy tabulations and data tapes; originals of all
test materials; all correspondence relating to the research; the names, ad-
dresses, and background information of all consultants; the names and ad-
dresses of all funding sources; and the names and telephone numbers of all re-
spondents who were excluded from the study.
Given the published implications of my research, I had assumed that I
might at some point be deposed about this study.  I was, however, not prepared
to receive a subpoena of this breadth and one that would require turning over
the names of three- to six-year-old children.  Such disclosure would have vio-
lated written confidentiality agreements that I had signed with each parent be-
fore conducting the research.
I had also anticipated that the Medical College of Georgia (“MCG”), on
whose faculty I was a full professor and under whose auspices the research had
been conducted, would provide appropriate legal support for my position.
However, Michael Bowers, the Attorney General of the State of Georgia and
the official counsel for the medical school, took the position that the prevailing
legal issue was not human subject confidentiality, academic freedom, or the
reasonableness of the subpoena power, but rather the Georgia Open Records
Act, a law designed to permit public access to “official records.”14  Mr. Bowers
took this position even though RJR did not, at that time, request the records
via the Open Records Act. I refused to comply with the subpoena and MCG
refused to provide me with legal assistance.
I contacted my own lawyer, Robert W. Hunter, III, who prepared a motion
to quash the RJR subpoena.15  On April 28, 1992, Chief Superior Court Judge
William M. Fleming, Jr., ruled in favor of our motion to quash.16  RJR immedi-
ately appealed the ruling to the Georgia Court of Appeals, but that court, on
February 9, 1993, ruled in our favor arguing that the requested documents were
beyond the bounds of reasonable discovery.17
Two weeks later, in an article in a local newspaper, MCG lawyer Clay
Stedman stated that the school had not supported my legal efforts because of
their position on the Open Records Act.18  Stedman said that MCG “decline[d]
to object to [the] release of this information on the basis that although it was
not an Open Records [Act] request, Open Records would have required us to
release it.”19  Ironically, RJR attorneys did not know of MCG’s position on this
                                                          
14. Open Records Act, GA. CODE ANN. § 50-18-70 to -76 (Supp. 1996).
15. Motion to Quash, Fischer v R.J. Reynolds Tobacco Co., No. 93-RCCV-230 (Ga. Super. Ct.
Richmond County , Apr. 16, 1992).
16. See Fischer v R.J. Reynolds Tobacco Co., No. 93-RCCV-230 (Ga. Super. Ct. Richmond
County , Apr. 28, 1992) (order granting motion to quash).
17. See R.J. Reynolds Tobacco Co. v Fischer, 207 Ga. App. 292 (1993).
18. Kathleen Donahue, Researcher Has Hefty Legal Fees, THE AUGUSTA CHRONICLE, Feb. 27,
1993, at 17A.
19. Id.
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issue and had previously admitted in their Court of Appeals brief that they be-
lieved the records were not accessible to them under the Open Records Act be-
cause the research had not been supported by state funds.20
One week after the publication of this article, James R. Johnson, legal
counsel for RJR sent a letter to H. Dean Propst, Chancellor of the University
System of Georgia, and subsequently to Francis Tedesco, President of MCG,
requesting that my research records be released to RJR under the Open Rec-
ords Act.21  I was given forty-eight hours to turn over all of the previously de-
scribed records with the exception of the children’s names.  Clay Stedman, as
MCG legal counsel, indicated that I would be suspended if I did not turn over
the documents.  Francis Tedesco, M.D., President of MCG, indicated that the
Attorney General would have me arrested if I did not comply with the request.
At the advice of my lawyer, I turned all of the documents over to the court
for protection until such time as the legal issues relating to the Open Records
Act, academic freedom, and human subject confidentiality could be resolved.
The court accepted the documents and approved a temporary restraining order
against the Open Records request.22
One month later, RJR petitioned the court to assist MCG and the Attorney
General in the action against me.23  Both the Attorney General’s Office and
MCG supported RJR’s compelled disclosure motion.24  Ironically, this action
united the medical school and a tobacco company against one of the school’s
own faculty members.
On August 12, 1993, I received a nine-page letter listing documents and
data requested by RJR through the Open Records Act.25  It stated that RJR
wanted all documentation related to the study regardless of when it was gener-
ated or by whom.26  In response to a 1993 change in the Open Records Act
which excluded release of the names of research participants, RJR did request
that the subject names be redacted from the submitted documents.
On December 1, 1993, I resigned from the faculty of MCG and entered pri-
vate practice in Augusta.  On July 20, 1994, Judge John H. Ruffin signed an
RJR request to release all of the records held by the court.  The records were
released to an RJR lawyer before we were notified of the decision, making an
appeal of this decision moot.
                                                          
20. Petitioner’s Brief, R.J. Reynolds Tobacco v. Fischer, 207 Ga. App. 292 (1993).
21. Letter from James R. Johnson, Legal Counsel, RJR, to Francis J. Tedesco, President, MCG
(Mar. 10, 1993) (on file with author).
22. Motion for Temporary Restraining Order, Fischer, No. 93-RCCV-230 (Ga. Super. Ct. Rich-
mond County , Mar. 12, 1993).
23. See James R. Johnson’s Motion to Intervene as a Defendant, Fischer, No. 93-RCCV-230 (Ga.
Super. Ct. Richmond County, Apr. 22, 1993).
24. Letter from David M. Monde, Attorney, Jones Day, Reavis & Pogue, to Kathryn L. Allen,
Senior Assistant Attorney General (Apr. 20, 1993) (on file with author).
25. Letter from RJR to author (Aug. 12, 1993) (on file with author).
26. See id.
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B.  Lessons Learned
Every day in every academic institution, people request information from
scientists.  Most of the time this is done by fellow scientists in the process of
scientific research.  For example, after the publication of the “Old Joe” study, I
received requests from other researchers for specific information about our
study and how it was done.  Such requests are usually limited to information
that would permit replication of the research.  Successful replication is essential
to establish scientific validity, and therefore scientists are usually pleased to
share information.
Scientists do not use subpoenas to seek scientific truth!  Thus, the subpoena
of a researcher’s files is evidence that the process has moved outside of the
realm of scientific inquiry.  As the cases cited in this paper illustrate, a sub-
poena usually means that the research in question has commercial implications
and that a company has decided that its lawyers, rather than its scientists, are in
the best position to protect the company’s interests.
Nevertheless, many subpoenas for research are routine.  For example, a
medical researcher might discover and report a series of side-effects in patients
taking a new drug.  The pharmaceutical company that manufactures the drug
may then subpoena the records to see if there is an alternative explanation for
the patients’ symptoms.  Other than concerns about patient confidentiality,
such a subpoena would be handled in a routine fashion.
However, not all compelled disclosure is routine.  In the extreme, subpoe-
nas can be unwittingly used in a manner that is damaging to the researcher, the
scientific process, and the greater public good.
III
DAMAGING EFFECTS OF EXTREME SUBPOENAS
A.  Discredit the Research.  Discredit the Researcher.
It was clear from the U.S.A. Today interview that RJR wanted to discredit
me and my research.27  Furthermore, this refutation would not follow the usual
“rules” of science.
The standards for a published scientific paper require that the report in-
clude sufficient detail about the scientific methods utilized so that another indi-
vidual in the field could duplicate the study.  This was precisely what Advertis-
ing Age did after initially expressing reservations about the “Old Joe” research.
They commissioned research that was published five months later and showed
that the Camel campaign was indeed highly effective in reaching young people,
especially children younger than age thirteen.28  The president of the research
company said, “I was blown away by the number of smaller kids who could
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name cigarettes.”29  Had RJR been concerned about the veracity of our find-
ings, they could have duplicated our research in several weeks for a few thou-
sand dollars.  Instead, they spent two and a half years, and a great deal more
money, in an attempt to access every page in my files.
Why would RJR be interested in every scrap of paper in a research file?
The answer to this question became clear from the experience of Dr. Joseph
DiFranza, the lead author of one of the “Old Joe” studies.30  His research
showed that Camel cigarettes’ share of the youth market increased from a mere
0.5% to a substantial 32.8% following the “Old Joe” advertising campaign.31
Dr. DiFranza received a similar subpoena and turned over his records to RJR.
In one of the letters to a colleague that was included in the disclosed docu-
ments, Dr. DiFranza wrote, “I have an idea for a project that will give us a cou-
ple of smoking guns to bring to the national media.”32  RJR released this letter
to the press and claimed that it proved that the researchers were biased and
that the research was fraudulent.33
It is easy to characterize any scientist as being biased.  The public assumes
that scientists enter into research without a point of view.  Nothing could be
further from the truth.  Science is impossible to do without passion about an
idea.  Scientists are not without opinions, but they agree to subject these opin-
ions to objective experiments to see if they are true.  In every researcher’s files,
there are notes that could be taken out of context and characterized as proving
bias.
In addition, every research study represents a series of methodological deci-
sions about how data are collected and analyzed.  These decisions require ex-
pert judgment and each of these judgments, when viewed in isolation, could be
challenged.  It is precisely because of this, that the final published paper be-
comes the record of the research.  In the published manuscript, the researcher
must describe the findings, discuss their meaning, and most importantly, iden-
tify the study’s limitations.
The broad subpoena filed by RJR is akin to requiring a Supreme Court Jus-
tice to report every private note made and every comment spoken in consider-
ing a case, rather than merely being responsible for the contents of the final
opinion.  It would be quite easy to discredit the decisions of even the best
judges if their private notes and thoughts were publicly open on demand.
B.  Human Subject Confidentiality
The conduct of research on human subjects requires that the public have
confidence that its best interests will be protected and that its confidentiality
will be preserved.  In the case of our research, RJR requested the names and
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32. See Maria Mallory, That’s One Angry Camel, BUS. WK., Mar. 7, 1994, at 94.
33. See id.
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addresses of 239 three- to six-year-old children whose parents had signed
agreements in which we promised complete confidentiality.  According to
Peggy Carter, an RJR spokesperson, the company intended to use this informa-
tion to contact the research subjects.34  Her reason for requesting this breach of
confidentiality was that “[t]here have been a number of stories that have come
up in recent years where scientists claimed to have produced research that …
was never done at all.”35  While this reasoning is paranoid at best, it would not
be necessary for RJR to knock on children’s doors at night to prove that the
data in question were collected, rather than fabricated.
The issue of subject confidentiality took an interesting legal turn in my case.
MCG initially acknowledged the potential for abuse.  In a letter from Carol
Huston, one of the school’s attorneys, to the Attorney General’s office, she
stated that
[Fischer’s] concern, which I believe is well founded, is that Reynolds is attempting to
harass him (and other researchers) through tactics such as this in order to discourage
future research, the results of which may not be favorable to the tobacco industry… .
We also believe if [RJR] obtains the names of the respondents, it seems very likely
that [it] may contact them and attempt to harass them.  This, in turn, may discourage
other individuals from participating in future research projects.
Despite these observations by an MCG lawyer, the Attorney General’s po-
sition prevailed, and the school insisted that all names be released.
As a general matter, institutions that participate in federally funded medical
research must sign agreements with the Department of Health and Human
Services (“DHHS”), by which they agree to conduct research according to fed-
erally-established guidelines.  Human subject confidentiality is well-protected
by these standards.  My study, however, was not federally funded and was sub-
ject to these guidelines only because of contractual agreements between DHHS
and MCG.
On September 8, 1992, I was contacted by the acting chief of the Office of
Protection from Research Risks of the National Institutes of Health.  He had
heard of my case and wanted information about any breach of human subject
protection.  He subsequently sent a letter to the school alleging noncompliance
with their DHHS contract because of the school’s position requiring release of
my subjects’ names.  The school responded that the federal regulations could
be avoided because my research was not federally funded.  DHHS and MCG
subsequently signed a revised contract in which only federally funded research
was governed by federal regulations regarding subject confidentiality.
C.  Harassment
The tobacco industry approach to litigation has been described by Lawton
M. Chiles, Jr., Governor of the State of Florida, as “designed to confuse the
medical evidence, stone-wall, delay, refuse reasonably to settle claims, and to
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run up plaintiffs’ attorneys’ fees in a war of attrition.”36  He cites a memo writ-
ten by J. Michael Jordan, an attorney for RJR:
The aggressive posture we have taken regarding depositions and discovery in general
continues to make these cases extremely burdensome and expensive for plaintiffs’
lawyers, particularly sole practitioners.  To paraphrase General Patton, the way we
won these cases was not by spending all of Reynolds’ money, but by making the other
son of a bitch spend all his.37
This same approach was used to wear down my resources, including my
time, attention, and money.  The ultimate goal is to make the process suffi-
ciently painful so that the researcher cannot complete further research and so
that other scientists are discouraged from conducting similar studies.
Scientists are perfect subjects for harassment by litigation.  They often have
little knowledge of the law and little patience for the slow and subtle workings
of the legal system. The distraction and anxiety caused by depositions, legal
costs, and court appearances can easily put an abrupt end to a promising line of
research or a research career.
It should be noted that RJR did not limit its harassment efforts to the use of
the press and the courts.  It also attempted to conscript the institution at which
I worked.  Bernard Wagner, M.D., Professor at the New York University
School of Medicine and paid consultant to RJR, contacted my research col-
leagues and the President of MCG with accusations of scientific fraud.38  A
similar letter was sent to the University of Massachusetts regarding Dr. Di-
Franza’s “Old Joe” study.39  While MCG did not respond, the University of
Massachusetts used these baseless accusations to initiate scientific misconduct




As a researcher who has been through the experience of compelled disclo-
sure, many of the suggestions outlined in this paper do not appear to be viable
solutions to the problem that I faced.  I would not argue that scientists deserve
special protection under the law in the same way that lawyers, priests, or jour-
nalists have claimed the need for protection of their relationships with clients,
parishioners, and confidential sources.  Science, after all, is based on a shared
and open search for truth.  I am not, however, so naive as to believe that most
subpoenas for research records are based on goodwill, public interests, or the
search for truth.  I offer the following thoughts:
                                                          
36. Complaint, Florida v. American Tobacco Co. et al., No. CL-1466A0 (Circuit Ct.,15th Circuit,
Palm Beach. Fla., Apr. 18, 1995)
37. Id. at 28-29 (memorandum from J. Michael Jordan, legal counsel, RJR).
38. Letter from Bernard Wagner to Tina Rojar (Mar. 29, 1993) (on file with author).
39. Based on the author’s conversations with Dr. DiFranza.
40. Id.
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First, if a request for compelled disclosure has been made, realize that the
process has moved outside of the normal exchange between scientists.  It is
likely that a commercial entity and its profits are at stake.  It is also likely that
the company will have greater legal resources and experience than the scientist,
who may have never stepped foot inside a courtroom.
Second, despite institutional affiliation and responsibilities to protect aca-
demic freedom, universities may provide poor legal counseling to scientists
facing compelled disclosure.  This problem may become greater due to the in-
creased reliance of universities on corporate support.  We might expect to see
university presidents siding with corporate contributors rather than their aca-
demic faculty.
Next, if a subpoena is requested by an industry, consider the industry’s past
record in dealing with the scientific community.  Consider whether the industry
has used the legal system to discourage good science in the past.
Also, consider the breadth of the request.  If it goes far beyond what a rea-
sonable scientist would require to duplicate the research, then there may be
other ways that the company could validate the research findings without vio-
lating the privacy of the scientist’s records.
Ask the scientist to identify specifically how compelled discovery could im-
pede his research.  It is impossible for the court to balance the rights of the
company with those of the scientist unless it understands the implications of the
legal process on the scientist’s time, attention, and financial resources.
Finally, human subject confidentiality, promised as part of the research
process, must be protected at all costs.  There are excellent ways to identify sci-
entific fraud without violating anonymity, such as the use of an independent re-
view panel of scientists.
V
CONCLUSION
The uneasy relationship between law and science is likely to continue re-
garding disclosure of scientific research materials.  Law and science are worlds
apart in terms of values that they hold and the rules that they follow.  Whether
it be DNA evidence or silicone breast implants, it appears that these two
worlds will collide with ever-increasing frequency.  This inevitable collision will
require that scientists have a better understanding of the legal implications of
their research and that judges have a better understanding of the impact of
their decisions on the progress of science.
